Specialty logistics provider World Courier announces expansion

© Shutterstock

Specialty logistics company World Courier said Tuesday it will open three transport stations across the country to expand its presence, as well as its capacity to deliver specialized logistics support.

In response to a growing specialty pharmaceutical market, World Courier said it will open stations in Denver, Indianapolis and San Diego. The company, part of Cencora (formerly Amerisource Bergen), said the expansion will increase its ability to store, handle and transport complex specialty pharmaceutical products. Its Indianapolis facility will be equipped to handle liquid nitrogen (LN2), and will add to its network of LN2 charging centers and stations, allowing the company to better handle products that require cryogenic storage.

“As more complex and sensitive pharmaceutical products enter clinical development, the demand for highly specialized logistics continues to increase,” Matt Virgilio, regional vice president of North America for World Courier, said. “By expanding our network and capabilities, we are well-positioned to support our partners’ evolving needs and deliver the solutions required to protect products throughout transport whether it’s a commercially approved cell and gene therapy product or a vaccine in clinical development.”

The company said it had also recently launched a Container Freight Station at its New Hyde Park facility in New York. That facility, along with approval from the U.S. Customs and Border Protection, will allow World Courier to store shipments while awaiting customs clearance, instead of having them stored with the airline. The increased control over storage will help the courier company deliver enhanced temperature control management, including real-time temperature and humidity monitoring, and allow it to expedite the shipping process.

“As our partners develop and bring to market innovative new products, such as cell and gene therapies, they trust us to deliver the solutions needed to ensure their therapies can reach the patients who need them — no matter where they are,” Nick Porter, president of World Courier, said. “These continued investments enable us to evolve alongside our partners and deliver the specialty logistics solutions needed to support the unique requirements of the products being developed today.”